Eva Iniguez, Nathaniel S Schocker, Krishanthi Subramaniam, Susana Portillo, Alba L Montoya, Waleed S Al-Salem, . . . Rosa A Maldonado. (2017). An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationEva Iniguez, et al. An α-Gal-containing Neoglycoprotein-based Vaccine Partially Protects Against Murine Cutaneous Leishmaniasis Caused by Leishmania Major. Public Library of Science (PLoS), 2017.
MLA (9th ed.) CitationEva Iniguez, et al. An α-Gal-containing Neoglycoprotein-based Vaccine Partially Protects Against Murine Cutaneous Leishmaniasis Caused by Leishmania Major. Public Library of Science (PLoS), 2017.
Warning: These citations may not always be 100% accurate.